
Headsafe is a dynamic Australian medtech company that has developed the Nurochek, a portable brain assessment device designed to aid in the diagnosis of concussion. The Nurochek device provides an objective assessment in just 2 minutes, utilizing a patented machine learning algorithm to analyze brain responses to visual stimuli. With FDA clearance and a focus on standardizing evaluations across healthcare facilities, Headsafe aims to revolutionize concussion assessment and improve patient outcomes. The company has grown rapidly since its incorporation in 2017, winning multiple awards and establishing a strong presence in the medtech industry.

Headsafe is a dynamic Australian medtech company that has developed the Nurochek, a portable brain assessment device designed to aid in the diagnosis of concussion. The Nurochek device provides an objective assessment in just 2 minutes, utilizing a patented machine learning algorithm to analyze brain responses to visual stimuli. With FDA clearance and a focus on standardizing evaluations across healthcare facilities, Headsafe aims to revolutionize concussion assessment and improve patient outcomes. The company has grown rapidly since its incorporation in 2017, winning multiple awards and establishing a strong presence in the medtech industry.